Innovative Testing Solutions
By combining our precise, rapid, microbial identification technology with a deep understanding of the unique challenges faced by those with cystic fibrosis, we aim to enhance the quality of life for patients and contribute to a future where early, accurate microbial identification becomes a cornerstone in the management of this complex condition.
Our Mission
Our work will revolutionise healthcare for individuals with cystic fibrosis by providing precise and rapid microbial identification enabling timely and targeted interventions. Our dedication to excellence, scientific integrity and compassionate care drives us to push boundaries, ultimately transforming the landscape of cystic fibrosis healthcare and bringing hope to individuals and their families worldwide.
Our goal is to provide accurate and timely diagnostic solutions for microbial infections, improving patient outcomes and quality of life in various healthcare settings
Infectious Disease Testing
We develop rapid point of care tests for microbial infections in infectious disease
Cystic Fibrosis Testing Kit
Rapid Pseudomonas aeruginosa detection (RPaD) in people with cystic fibrosis.
Early Diagnosis
Management of Exacerbation
Cessation of long term inhaled antibiotics
Our Leadership
Our strength lies in our innovate ability, multidisciplinary approach and inclusion of healthcare professionals from the get go. Set up by Dr Shaun Robertson and Dr Simone Lucanto, the team strives to bring in the best talent to deliver our goals.
Dr Shaun N Robertson
CEO & Co-Founder
Simone Lucanto
CTO & Co-founder
Hayden Jeffreys
Chairperson
